Pseudosubstrate regulation of the SCFβ-TrCP ubiquitin ligase by hnRNP-U

  1. Matti Davis1,
  2. Ada Hatzubai1,
  3. Jens S. Andersen2,
  4. Etti Ben-Shushan1,
  5. Gregory Zvi Fisher1,
  6. Avraham Yaron1,
  7. Asne Bauskin3,
  8. Frank Mercurio4,
  9. Matthias Mann2, and
  10. Yinon Ben-Neriah1,5
  1. 1The Lautenberg Center for Immunology, The Hebrew University–Hadassah Medical School, Jerusalem 91120, Israel; 2Protein Interaction Laboratory, University of Southern Denmark, DK-5230 Odense M, Denmark; 3Centre for Immunology, St. Vincent's Hospital and University of New South Wales, Sydney 2010, Australia; 4Signal Research Division, Celgene Corp., San Diego, California 92121, USA

Abstract

β-TrCP/E3RS (E3RS) is the F-box protein that functions as the receptor subunit of the SCFβ-TrCP ubiquitin ligase (E3). Surprisingly, although its two recognized substrates, IκBα and β-catenin, are present in the cytoplasm, we have found that E3RS is located predominantly in the nucleus. Here we report the isolation of the major E3RS-associated protein, hnRNP-U, an abundant nuclear phosphoprotein. This protein occupies E3RS in a specific and stoichiometric manner, stabilizes the E3 component, and is likely responsible for its nuclear localization. hnRNP-U binding was abolished by competition with a pIκBα peptide, or by a specific point mutation in the E3RS WD region, indicating an E3–substrate-type interaction. However, unlike pIκBα, which is targeted by SCFβ-TrCP for degradation, the E3-bound hnRNP-U is stable and is, therefore, a pseudosubstrate. Consequently, hnRNP-U engages a highly neddylated active SCFβ-TrCP, which dissociates in the presence of a high-affinity substrate, resulting in ubiquitination of the latter. Our study points to a novel regulatory mechanism, which secures the localization, stability, substrate binding threshold, and efficacy of a specific protein-ubiquitin ligase.

Keywords

Footnotes

  • 5 Corresponding author.

  • E-MAIL yinon{at}cc.huji.ac.il; FAX 972-2-642-4653.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.218702.

    • Received October 15, 2001.
    • Accepted December 15, 2001.
| Table of Contents

Life Science Alliance